Oxaliplatin
Common brands: Efudex, Tolak, Fluorouracil, Xeloda, Avastin
Top reporter: Accord Healthcare Inc.
Platinum-based Drug [EPC]Nucleoside Metabolic Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Corticosteroid [EPC]Epidermal Growth Factor Receptor Antagonist [EPC]
71,866
Total Reports
36,751
Serious Reports
10,538
Death Reports
30
Reported Reactions
Death Report Ratio: High (14.66%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Oxaliplatin.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DIARRHOEA | 6,739 | |
| 2 | NAUSEA | 5,280 | |
| 3 | OFF LABEL USE | 4,512 | |
| 4 | VOMITING | 4,300 | |
| 5 | DISEASE PROGRESSION | 4,235 | |
| 6 | NEUROPATHY PERIPHERAL | 4,158 | |
| 7 | NEUTROPENIA | 4,129 | |
| 8 | THROMBOCYTOPENIA | 3,459 | |
| 9 | DYSPNOEA | 2,999 | |
| 10 | PYREXIA | 2,819 | |
| 11 | FATIGUE | 2,697 | |
| 12 | ANAEMIA | 2,365 | |
| 13 | ASTHENIA | 2,312 | |
| 14 | DEATH | 2,290 | |
| 15 | DRUG INEFFECTIVE | 2,096 | |
| 16 | DECREASED APPETITE | 2,078 | |
| 17 | ABDOMINAL PAIN | 1,985 | |
| 18 | FEBRILE NEUTROPENIA | 1,782 | |
| 19 | MALIGNANT NEOPLASM PROGRESSION | 1,621 | |
| 20 | MYELOSUPPRESSION | 1,611 | |
| 21 | PARAESTHESIA | 1,588 | |
| 22 | RASH | 1,563 | |
| 23 | NEUROTOXICITY | 1,456 | |
| 24 | DEHYDRATION | 1,441 | |
| 25 | HYPERTENSION | 1,417 | |
| 26 | PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME | 1,379 | |
| 27 | ERYTHEMA | 1,377 | |
| 28 | MALAISE | 1,368 | |
| 29 | HYPOTENSION | 1,351 | |
| 30 | LEUKOPENIA | 1,297 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.